koko体育app

欢迎来到《koko体育app 学报（医学版）》
刘一君, 刘进. 植入冠脉支架患者择期非心脏手术的围术期抗血小板治疗方案探究[J]. koko体育app 学报（医学版）, 2022, 53(1): 49-53. DOI:
引用本文: 刘一君, 刘进. 植入冠脉支架患者择期非心脏手术的围术期抗血小板治疗方案探究[J]. koko体育app 学报（医学版）, 2022, 53(1): 49-53. DOI:
LIU Yi-jun, LIU Jin. Perioperative Antiplatelet Therapy in Patients with Coronary Stents Undergoing Elective Non-Cardiac Surgery[J]. Journal of Sichuan University (Medical Sciences), 2022, 53(1): 49-53. DOI:
Citation: 🧸 LIU Yi-jun, LIU Jin. Perioperative Antiplatelet Therapy in Patients with Coronary Stents Undergoing Elective Non-Cardiac Surgery[J]. Journal of Sichuan University (Medical Sciences), 2022, 53(1): 49-53. DOI:

植入冠脉支架患者择期非心脏手术的围术期抗血小板治疗方案探究

Perioperative Antiplatelet Therapy in Patients with Coronary Stents Undergoing Elective Non-Cardiac Surgery

  • 摘要: 植入冠脉支架患者正在逐渐成为接受择期非心脏手术（non-cardiac surgery, NCS）的患者中不可忽视的一个群体。既往心脏疾病、冠脉支架以及抗血小板药物使这类患者在围术期面临着血栓形成和出血的双重风险。制定适宜的围术期抗血小板治疗方案将有助于降低风险，保障患者安全。本文将围绕目前支架患者择期NCS围术期抗血小板治疗的各个环节总结分析现有治疗方案，并探讨该领域未来的研究方向。  
    Abstract: Among patients undergoing elective non-cardiac surgery (NCS), those with coronary stent implants are gradually becoming a patient group that cannot be easily overlooked. Previous history of heart disease, coronary stents and antiplatelet agents expose these patients to dual perioperative risks of thrombosis and bleeding. Formulating appropriate plans for perioperative antiplatelet therapy will help reduce the risks and ensure the safety of patients. We herein reviewed and analyzed various aspects of perioperative antiplatelet therapy for patients with coronary stent implants undergoing elective NCS, and discussed prospective research directions in the field.  
    • HTML全文
© 2022 《koko体育app 学报（医学版）》编辑部　版权所有 cc

开放获取💞 本文遵循知识共享署名—非商业性使用4.0国际许可协议（CC BY-NC 4.0），允许第三方对本刊发表的论文自由共享（即在任何媒介以任何形式复制、发行原文）、演绎（即修改、转换或以原文为基础进行创作），必须给出适当的署名，提供指向本文许可协议的链接，同时标明是否对原文作了修改；不得将本文用于商业目的。CC BY-NC 4.0许可协议详情请访问

/

返回文章
返回
var _hmt = _hmt || []; (function() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })(); !function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7iMpaU8NS42Fm",ck:"K9y7iMpaU8NS42Fm"}); koko体育-koko体育app koko体育-koko体育网页版koko体育app koko体育-全站app下载(官网) m6米乐app|下载 m6米乐app|主頁欢迎您!!